Why is Berkshire Hathaway's cash pile hitting records?
How is the government shutdown impacting SNAP benefits?
What caused Chipotle's stock to plummet recently?
Why is Nvidia leading the AI chip market surge?
How are rising energy prices affecting data centers?
Why did US tariffs on heavy trucks and buses start?
What’s behind OpenAI’s bullish revenue projections?
AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%
investors.com/news/technology/abbvie-stock-abbvie-earnings-q3-2025/?src=A00220
leaned hard on Skyrizi, Rinvoq and Botox to offset continued steep declines from Humira and its aesthetics division, an analyst said Friday as AbbVie stock dipped.
Skyrizi, an immunology drug that treats conditions like psoriasis and arthritis, is now AbbVie's biggest moneymaker. In the…
This story appeared on investors.com, 2025-10-31 13:45:58.